Cargando…
Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
BACKGROUND: We sought to determine whether suboptimal chemotherapy compromised the prognosis of osteosarcoma patients. METHODS: A total of 132 eligible patients who underwent chemotherapy between 1998 and 2008 were identified in our database. Information regarding patient demographics, clinical char...
Autores principales: | Yong, Bicheng, Tan, Pingxian, Yin, Junqiang, Zou, Changye, Xie, Xianbiao, Wang, Jin, Huang, Gang, Wang, Qianyong, Shen, Jingnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545907/ https://www.ncbi.nlm.nih.gov/pubmed/22985081 http://dx.doi.org/10.1186/1477-7819-10-191 |
Ejemplares similares
-
Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma
por: Wang, Bo, et al.
Publicado: (2015) -
Experience with periprosthetic infection after limb salvage surgery for patients with osteosarcoma
por: Lin, Tiao, et al.
Publicado: (2021) -
Comparison of clinical features, management and outcomes of osteosarcoma located in proximal fibula and proximal tibia: a propensity score matching analysis
por: Yao, Hao, et al.
Publicado: (2018) -
Development and validation of a prognostic index to predict pulmonary metastasis of giant cell tumor of bone
por: Wang, Bo, et al.
Publicado: (2017) -
Reconstruction with Modular Hemipelvic Endoprosthesis after Pelvic Tumor Resection: A Report of 50 Consecutive Cases
por: Wang, Bo, et al.
Publicado: (2015)